Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00063
|
|||||
| EM Name |
Aspartate
|
|||||
| Synonyms |
L-aspartic acid; aspartic acid; H-Asp-OH; L-aspartate; Asparagic acid; L-Aminosuccinic acid; (S)-2-Aminosuccinic acid; L-Asparagic acid; Aspatofort; (2S)-2-aminobutanedioic acid; Asparaginic acid; L-Asparaginic acid; (S)-Aspartic acid; (2S)-Aspartic acid; aspartate; (S)-Aminobutanedioic acid; L-Aspartinsaeure; L-Asparaginsaeure; L-Asparaginsyra; Aspartic acid, L-; Acidum asparticum; L-(+)-Aspartic acid; L-Asp; L-2-Aminobutanedioic acid; Aspartate, L-; Asparaginsaeure [German]; Aminosuccinic acid
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5960"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C4H7NO4
|
|||||
| Canonical SMILES |
C(C(C(=O)O)N)C(=O)O
|
|||||
| InChI |
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1
|
|||||
| InChIKey |
CKLJMWTZIZZHCS-REOHCLBHSA-N
|
|||||
| CAS Number |
CAS 56-84-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 133.1 | Topological Polar Surface Area | 101 | ||
| Heavy Atom Count | 9 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
-2.8
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17053
|
|||||
| DT(s) "handling" This EM | ARALAR1 | Transporter Info | Calcium-binding mitochondrial carrier protein Aralar1 | [1] | ||
| EAAT1 | Transporter Info | Excitatory amino acid transporter 1 | [2] | |||
| GC1 | Transporter Info | Mitochondrial glutamate carrier 1 | [3] | |||
| References | ||||||
| 1 | L-Lactate-Mediated Neuroprotection against Glutamate-Induced Excitotoxicity Requires ARALAR/AGC1. J Neurosci. 2016 Apr 20;36(16):4443-56. | |||||
| 2 | Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat Cell Biol. 2018 Jul;20(7):775-781. | |||||
| 3 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.